ALIVUS / Q4-FY26 / risks

Keep the risk register visible.

Alivus Life Sciences · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ4-FY26 · 2026-04-??Back to quarter ↗

Risk intelligence

Material risks this quarter

Geopolitical tariff and supply chain uncertainties

Ongoing geopolitical conflicts and tariff uncertainties could disrupt supply chains and increase logistics and energy costs.

medium

Raw material cost inflation from war

Solvent costs have increased significantly due to the war, though management expects to pass on costs to customers.

medium

Fire incident at H plant impact

A fire at the H plant impacted intermediate production, resulting in a 20 crore loss booked in other expenses, with minor spillover expected in Q1.

low

Potential delays in CDMO deal closures

Management moderated timing for two CDMO deals to early H2 FY27, indicating possible delays from earlier expectations.

low